Assignee
GUILIN EIGHT PLUS ONE PHARMACEUTICAL CO LTD
CN·0 granted patents·2 pending applications·0 citations·filing 2018–2018
Top patents by PatentIndex Score
2 records- 0134US2020188471A1Application of selective tnfr1 antagonist peptide sn10 in preparation of drugs for preventing and treating rheumatoid arthritisGUILIN EIGHT PLUS ONE PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 0232US2020277355A1Selective tnfr1 antagonist peptide sn10 and application thereof in inflammatory bowel diseaseGUILIN EIGHT PLUS ONE PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GUILIN EIGHT PLUS ONE PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →